Literature DB >> 23806382

Stent grafts for central venous occlusive disease in patients with ipsilateral hemodialysis access.

Anthony G Verstandig1, Daniel Berelowitz, Ibrahim Zaghal, Ilya Goldin, Oded Olsha, Bashar Shamieh, Vladimir Shraibman, David Shemesh.   

Abstract

PURPOSE: To assess long-term outcomes of stent grafts in patients with symptomatic central venous stenoses and occlusions ipsilateral to hemodialysis grafts or fistulas.
MATERIALS AND METHODS: The study included 52 of 55 consecutive patients with symptomatic stenoses of the central veins draining upper limb dialysis access grafts or fistulas treated with stent grafts. Indications for stent grafts were poor angioplasty results, rapid recurrence, or total occlusion. Endpoints were lesion patency and access patency following intervention. Mean follow-up was 25 months with a median of 24 months and 1.25 additional procedures per patient year. Patency rates were calculated using Kaplan-Meier analysis.
RESULTS: All stent grafts were successfully deployed. The lesion patency rates at 6, 12, 24, and 36 months after intervention were 60%, 40%, 28%, and 28%. The access patency rates at 6, 12, 24, and 36 months after intervention were 96%, 94%, 85%, and 72%. There was one major complication and no minor complications. In 40 patients (77%), the internal jugular vein confluence was covered by the stent graft. In five patients, the dialysis circuits became occluded, with no clinical sequelae in four; one patient was lost to follow-up. The contralateral brachiocephalic vein was covered in three patients (6%), preventing contralateral access construction in one patient.
CONCLUSIONS: Central vein stent graft placement in patients with hemodialysis access is associated with prolonged access patency. Coverage of major vein confluences, which occurred in 83% of the patients in this series, can compromise future access and should be avoided whenever possible by careful technique.
Copyright © 2013 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  PTA; percutaneous transluminal angioplasty

Mesh:

Year:  2013        PMID: 23806382     DOI: 10.1016/j.jvir.2013.04.016

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

Review 1.  A practical review of the use of stents for the maintenance of hemodialysis access.

Authors:  Michael Ginsburg; Jonathan M Lorenz; Sean P Zivin; Steven Zangan; Don Martinez
Journal:  Semin Intervent Radiol       Date:  2015-06       Impact factor: 1.513

2.  Dialysis catheter-related superior vena cava syndrome with patent vena cava: long term efficacy of unilateral Viatorr stent-graft avoiding catheter manipulation.

Authors:  Pietro Quaretti; Franco Galli; Lorenzo Paolo Moramarco; Riccardo Corti; Giovanni Leati; Ilaria Fiorina; Marcello Maestri
Journal:  Korean J Radiol       Date:  2014-04-29       Impact factor: 3.500

Review 3.  Endovascular Treatment for Venous Diseases: Where are the Venous Stents?

Authors:  Adeline Schwein; Yannick Georg; Anne Lejay; Philippe Nicolini; Olivier Hartung; David Contassot; Fabien Thaveau; Frédéric Heim; Nabil Chakfe
Journal:  Methodist Debakey Cardiovasc J       Date:  2018 Jul-Sep

4.  Physician-Modified Fenestrated Endovascular Repair for Iatrogenic Innominate Vein Injury.

Authors:  Kyung Bae Lee; Alyssa J Pyun; Jonathan Praeger; Kenneth R Ziegler; Sukgu M Han
Journal:  Vasc Specialist Int       Date:  2022-06-30

5.  Brachiocephalic Vein Stenting and Body-Floss Technique as a Treatment of CVD in Dialysis-Dependent Patient - Case Report and Literature Review.

Authors:  Róża Krycińska; Agata Trznadel; Paulina Kuchalska; Michał Lis; Bartosz Dołęga-Kozierowski; Krzysztof Dyś; Stanisław Drelichowski; Wojciech Witkiewicz
Journal:  Pol J Radiol       Date:  2015-05-10

6.  Outcomes of Central Venoplasty in Haemodialysis Patients.

Authors:  Gary Andrew Cuthbert; Zhiwen Joseph Lo; Justin Kwan; Sadhana Chandrasekar; Glenn Wei Long Tan
Journal:  Ann Vasc Dis       Date:  2018-09-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.